Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease

Fulltext:
207891.pdf
Embargo:
until further notice
Size:
504.3Kb
Format:
PDF
Description:
publisher's version
Publication year
2019Source
Journal of Crohn's and Colitis, 13, 7, (2019), pp. 838-845ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Health Evidence
Haematology
Gastroenterology
Human Genetics
Psychiatry
IQ Healthcare
Otorhinolaryngology
Journal title
Journal of Crohn's and Colitis
Volume
vol. 13
Issue
iss. 7
Page start
p. 838
Page end
p. 845
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 0: Other Research RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 13: Stress-related disorders DCMN: Donders Center for Medical Neuroscience; Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience; Radboudumc 5: Inflammatory diseases RIHS: Radboud Institute for Health Sciences; Radboudumc 7: Neurodevelopmental disorders DCMN: Donders Center for Medical NeuroscienceThis item appears in the following Collection(s)
- Academic publications [227881]
- Electronic publications [107344]
- Faculty of Medical Sciences [86219]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.